エーザイの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/08/12 | 9,700 | 9,762 | 9,188 | 9,292 | -519 | -5.3% | 1,544,600 |
2020/08/11 | 9,226 | 9,890 | 9,223 | 9,811 | +1,185 | +13.7% | 2,951,200 |
2020/08/07 | 8,688 | 8,690 | 8,537 | 8,626 | +88 | +1% | 578,400 |
2020/08/06 | 8,628 | 8,667 | 8,489 | 8,538 | -125 | -1.4% | 523,600 |
2020/08/05 | 8,760 | 8,760 | 8,550 | 8,663 | -88 | -1% | 568,200 |
2020/08/04 | 8,800 | 8,970 | 8,733 | 8,751 | -26 | -0.3% | 629,500 |
2020/08/03 | 8,637 | 8,839 | 8,505 | 8,777 | +290 | +3.4% | 889,300 |
2020/07/31 | 8,710 | 8,746 | 8,472 | 8,487 | -297 | -3.4% | 628,700 |
2020/07/30 | 8,750 | 8,812 | 8,680 | 8,784 | -11 | -0.1% | 359,200 |
2020/07/29 | 8,785 | 8,863 | 8,776 | 8,795 | +10 | +0.1% | 327,400 |
2020/07/28 | 8,840 | 8,871 | 8,753 | 8,785 | +39 | +0.4% | 443,900 |
2020/07/27 | 8,636 | 8,815 | 8,630 | 8,746 | +4 | ±0% | 615,000 |
2020/07/22 | 8,667 | 8,775 | 8,640 | 8,742 | -25 | -0.3% | 462,900 |
2020/07/21 | 8,608 | 8,815 | 8,608 | 8,767 | +217 | +2.5% | 642,900 |
2020/07/20 | 8,475 | 8,572 | 8,454 | 8,550 | +41 | +0.5% | 372,100 |
2020/07/17 | 8,489 | 8,618 | 8,441 | 8,509 | +164 | +2% | 912,900 |
2020/07/16 | 8,447 | 8,504 | 8,312 | 8,345 | -116 | -1.4% | 947,300 |
2020/07/15 | 8,568 | 8,585 | 8,425 | 8,461 | -154 | -1.8% | 1,064,700 |
2020/07/14 | 8,625 | 8,723 | 8,575 | 8,615 | -24 | -0.3% | 484,700 |
2020/07/13 | 8,776 | 8,786 | 8,504 | 8,639 | -84 | -1% | 823,600 |
2020/07/10 | 8,948 | 8,972 | 8,719 | 8,723 | -225 | -2.5% | 1,134,700 |
2020/07/09 | 8,850 | 9,078 | 8,806 | 8,948 | +413 | +4.8% | 1,695,300 |
2020/07/08 | 8,519 | 8,624 | 8,492 | 8,535 | +41 | +0.5% | 642,100 |
2020/07/07 | 8,581 | 8,581 | 8,451 | 8,494 | -121 | -1.4% | 456,700 |
2020/07/06 | 8,542 | 8,638 | 8,496 | 8,615 | +95 | +1.1% | 296,600 |
2020/07/03 | 8,500 | 8,539 | 8,429 | 8,520 | +95 | +1.1% | 380,800 |
2020/07/02 | 8,536 | 8,558 | 8,416 | 8,425 | -123 | -1.4% | 535,900 |
2020/07/01 | 8,689 | 8,735 | 8,520 | 8,548 | +2 | ±0% | 596,500 |
2020/06/30 | 8,668 | 8,679 | 8,513 | 8,546 | +11 | +0.1% | 603,000 |
2020/06/29 | 8,653 | 8,694 | 8,507 | 8,535 | -212 | -2.4% | 514,400 |
2020/06/26 | 8,722 | 8,771 | 8,650 | 8,747 | +116 | +1.3% | 523,100 |
2020/06/25 | 8,550 | 8,720 | 8,515 | 8,631 | -39 | -0.4% | 703,700 |
2020/06/24 | 8,625 | 8,765 | 8,564 | 8,670 | +65 | +0.8% | 597,200 |
2020/06/23 | 8,553 | 8,658 | 8,361 | 8,605 | +86 | +1% | 667,200 |
2020/06/22 | 8,453 | 8,607 | 8,444 | 8,519 | +17 | +0.2% | 420,000 |
2020/06/19 | 8,598 | 8,598 | 8,436 | 8,502 | -60 | -0.7% | 951,300 |
2020/06/18 | 8,573 | 8,618 | 8,483 | 8,562 | +6 | +0.1% | 385,500 |
2020/06/17 | 8,665 | 8,665 | 8,530 | 8,556 | -142 | -1.6% | 637,200 |
2020/06/16 | 8,461 | 8,717 | 8,350 | 8,698 | +537 | +6.6% | 1,035,000 |
2020/06/15 | 8,330 | 8,462 | 8,150 | 8,161 | -210 | -2.5% | 548,100 |
2020/06/12 | 8,473 | 8,473 | 8,168 | 8,371 | -121 | -1.4% | 1,503,800 |
2020/06/11 | 8,660 | 8,710 | 8,482 | 8,492 | -404 | -4.5% | 1,199,900 |
2020/06/10 | 8,831 | 8,926 | 8,777 | 8,896 | +65 | +0.7% | 615,300 |
2020/06/09 | 8,929 | 8,948 | 8,756 | 8,831 | -79 | -0.9% | 695,500 |
2020/06/08 | 8,870 | 8,910 | 8,749 | 8,910 | +161 | +1.8% | 1,126,500 |
2020/06/05 | 8,580 | 8,756 | 8,555 | 8,749 | +116 | +1.3% | 702,500 |
2020/06/04 | 8,750 | 8,750 | 8,556 | 8,633 | -76 | -0.9% | 792,400 |
2020/06/03 | 8,663 | 8,817 | 8,625 | 8,709 | +146 | +1.7% | 836,400 |
2020/06/02 | 8,489 | 8,565 | 8,402 | 8,563 | +113 | +1.3% | 670,700 |
2020/06/01 | 8,463 | 8,544 | 8,414 | 8,450 | +12 | +0.1% | 838,600 |
1051~
1100
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
小野薬 | 174,700円 | -3.5% | -50.2% | 4.58% | 14.15倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム